[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,331
Citations 0
Biotech Innovations
June 11, 2019

Using Speech Markers to Diagnose PTSD

JAMA. 2019;321(22):2155. doi:10.1001/jama.2019.7550

Researchers seeking a less invasive, more objective way to classify posttraumatic stress disorder (PTSD) have become interested in speech-based biomarkers, building on previous work associating vocal changes with mood disorders. The current gold standard method for diagnosing PTSD, a structured interview called the Clinician-Administered PTSD Scale (CAPS), is lengthy, challenging for patients, and subject to the clinician’s interpretation.